Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new NEJM publication citation for Dostarlimab in primary advanced or recurrent endometrial cancer was added, listing authors and article details. The page revision history was updated from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-11T18:24:24.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a recent internal update to the site's revision. No visible content or user-facing changes are indicated.
    Difference
    0.0%
    Check dated 2026-07-21T12:38:58.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new publication citation has been added under Publications: 'Molecular Testing in Primary Advanced or Recurrent Endometrial Cancer: A Cost-Effectiveness Analysis' (JCO Precis Oncol, 2026). This update documents related research connected to the RUBY study.
    Difference
    0.0%
    Check dated 2026-07-14T09:31:41.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Two new scholarly references were added to the record, increasing the study's cited literature on dostarlimab-based therapy in endometrial cancer. The record revision was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:45.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now shows that enrollment is closed (no longer looking for participants) and adds new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) while updating the revision note to Revision: v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T17:55:18.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    A new NEJM publication citation is added to the study record, listing the Dostarlimab paper's authors and DOI, and the entry shows a new revision (v3.5.5).
    Difference
    0.1%
    Check dated 2026-06-08T14:51:55.000Z thumbnail image

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.